DESFERRIOXAMINE (DFO) INFUSION TEST MAY PREDICT BONE ALUMINUM (AL) DEPOSITS IN HEMODIALYZED (HD) PATIENTS

被引：0

作者：

BERLAND, Y

CHARHON, S

GRANVUILLEMIN, M

OLMER, M

机构：

[1] HOP CONCEPTION,SERV NEPHROL,F-13385 MARSEILLE 4,FRANCE

[2] INSERM,U234,F-69008 LYON,FRANCE

来源：

KIDNEY INTERNATIONAL | 1984年 / 26卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：539 / 539

页数：1

共 36 条

[31] IRON (FE) AND ALUMINUM (AL) CHELATION KINETICS DURING EXTENDED DEFEROXAMINE (DFO) THERAPY (RX) IN FE LOADED HEMODIALYSIS (HD) PATIENTS
STIVELMAN, J
HAKIM, R
SCHULMAN, G
FOSBURG, M
LAZARUS, JM
KIDNEY INTERNATIONAL, 1986, 29 (01) : 226 - 226
[32] MECHANISMS OF IMPROVEMENT IN ALUMINUM (AL) INDUCED MICROCYTIC ANEMIA (MA) FOLLOWING LONG-TERM DEFEROXAMINE (DFO) TREATMENT IN HEMODIALYSIS (HD) PATIENTS
ABREO, K
BROWN, ST
SELLA, ML
KIDNEY INTERNATIONAL, 1988, 33 (01) : 215 - 215
[33] LOW-DOSE DESFERRIOXAMINE TEST FOR THE DIAGNOSIS OF ALUMINUM-RELATED BONE-DISEASE IN PATIENTS ON REGULAR HEMODIALYSIS
YAQOOB, M
AHMAD, R
ROBERTS, N
HELLIWELL, T
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1991, 6 (07) : 484 - 486
[34] USE OF THE LOW-DOSE DESFERRIOXAMINE TEST TO DIAGNOSE AND DIFFERENTIATE BETWEEN PATIENTS WITH ALUMINUM-RELATED BONE-DISEASE, INCREASED RISK FOR ALUMINUM TOXICITY, OR ALUMINUM OVERLOAD
DHAESE, PC
COUTTENYE, MM
GOODMAN, WG
LEMONIATOU, E
DIGENIS, P
SOTORNIK, I
FAGALDE, A
BARSOUM, RS
LAMBERTS, LV
DEBROE, ME
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (10) : 1874 - 1884
[35] DIAGNOSIS OF ALUMINUM (AL) BONE-DISEASE IN LONG-TERM DIALYSIS PATIENTS USING DEFEROXAMINE (DFO) AND ZERO-CALCIUM DIALYSIS (ZCD)
ANDRESS, DL
OTT, SM
MILLINER, D
MALONEY, NA
ENDRES, D
COBURN, JW
SHERRARD, DJ
KIDNEY INTERNATIONAL, 1984, 25 (01) : 139 - 139
[36] VALUE OF THE DESFERAL INFUSION TEST FOR DIAGNOSIS OF ALUMINUM BONE-DISEASE IN PATIENTS WITH END-STAGE RENAL-FAILURE
MALLUCHE, HH
FAUGERE, MC
ALUMINIUM AND IRON OVERLOAD IN HAEMODIALYSIS, 1989, : 11 - 15

← 1 2 3 4 →